Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Pieris Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$24.80 | 0 |
| Dec 2025 | $7.00M | $7.00M - $7.00M | -$5.73M | -$23.20 | 1 |
| Dec 2024 | $6.63M | $6.63M - $6.63M | -$5.43M | -$16.00 | 1 |
| Dec 2023 | $31.98M | $27.35M - $36.61M | -$26.20M | -$28.00 | 1 |
| Dec 2022 | $26.57M | $26.57M - $26.57M | -$21.76M | -$50.744 | 1 |
| Dec 2021 | $31.41M | $31.41M - $31.41M | -$24.44M | -$56.40 | 1 |
| Dec 2020 | $31.25M | $31.25M - $31.25M | -$24.31M | -$52.80 | 1 |
| Dec 2019 | $33.82M | $33.82M - $33.82M | -$26.31M | -$60.80 | 1 |
| Dec 2018 | $30.08M | $30.08M - $30.08M | -$23.40M | -$38.20 | 1 |
| Dec 2017 | $13.89M | $13.89M - $13.89M | -$10.80M | -$51.40 | 1 |
| Dec 2016 | $4.67M | $4.67M - $4.67M | -$3.63M | -$42.667 | 1 |
| Dec 2015 | $1.10M | $1.10M - $1.10M | -$853.7K | -$37.60 | 1 |